EMA recommends approval of adapted Nuvaxovid COVID-19 vaccine targeting Omicron XBB.1.5

31 October 2023 - The EMA’s CHMP has recommended authorising an adapted Nuvaxovid vaccine targeting the Omicron XBB.1.5 subvariant of ...

Read more →

COVID-19 treatments to enter the market with a hefty price tag

28 October 2023 - The COVID-19 treatments millions of Americans have taken for free from the Federal Government will enter ...

Read more →

End of COVID-19 emergency response

20 October 2023 - A statement from Australia's Chief Medical Officer, Professor Paul Kelly, on the end of the COVID-19 emergency ...

Read more →

Pfizer to price Covid drug Paxlovid at $1,390 per course

18 October 2023 - Health insurance plans will likely pay much less than the nearly $1,400 list price for Paxlovid, ...

Read more →

EU delays approval of Novavax's revised COVID vaccine

16 October 2023 - European Union regulators have delayed a decision to give approval for Novavax's variant-tailored COVID-19 vaccine, the ...

Read more →

FDA authorises updated Novavax COVID-19 vaccine formulated to better protect against currently circulating variants

3 October 2023 - Today, the US FDA amended the emergency use authorisation of the Novavax COVID-19 vaccine, adjuvanted for use ...

Read more →

Swissmedic approves Moderna coronavirus vaccine Spikevax XBB.1.5

28 September 2023 - Spikevax XBB.1.5 approved for persons aged 18 and over ...

Read more →

Pfizer and BioNTech receive Health Canada authorisation for XBB.1.5 adapted monovalent COVID-19 vaccine

28 September 2023 - The updated vaccine is expected to be available in Canada in the coming weeks. ...

Read more →

Supply and insurance issues snarl fall COVID-19 vaccine campaign for some

20 September 2023 - It has been just over a week since the US FDA and the US Centers for ...

Read more →

Access to COVID-19 anti-viral treatments widened for more people at risk

20 September 2023 - PHARMAC is widening access to COVID-19 anti-virals to people who are vulnerable to severe infection from ...

Read more →

MHRA approves Moderna’s adapted COVID-19 vaccine (Spikevax) that targets Omicron XBB.1.5

15 September 2023 - The vaccine was approved after it was found to meet the MHRA’s standards of safety, quality and ...

Read more →

COVID-19 vaccine contract summary

18 September 2023 - The Ministry of Health has released a summary of the New Zealand Government’s procurement process for ...

Read more →

Spikevax: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5

14 September 2023 - EMA’s human medicines committee (CHMP) has recommended authorising an adapted Spikevax vaccine targeting the Omicron XBB.1.5 ...

Read more →

Health Canada authorises Moderna COVID-19 vaccine targeting the Omicron XBB.1.5 sub-variant

12 September 2023 - Health Canada has authorised the use of the Moderna Spikevax COVID-19 vaccine targeting the Omicron XBB.1.5 ...

Read more →

FDA takes action on updated mRNA COVID-19 vaccines to better protect against currently circulating variants

11 September 2023 - Today, the US FDA took action approving and authorising for emergency use updated COVID-19 vaccines formulated to ...

Read more →